Skip to content
  • Print

Genentech Fellowship | Clinical Science – Oncology Early Clinical Development

Genentech Logo Genentech's Oncology Early Clinical Development mission is to provide the clinical leadership and skills to successfully develop novel cancer therapies and the means by which to identify the patients who benefit from them. The organization is responsible for developing strategies for and executing on first-in-human, Phase 1 and Proof-of-Concept oncology clinical trials to assess the safety profile, tolerability, efficacy, pharmacokinetics, pharmacodynamics of new molecular entities. This two-year Clinical Science fellowship provides in-depth exposure to Oncology Early Clinical Development. In the role of Clinical Scientist, the fellow will gain experience in the basic principles of clinical oncology research while collaborating with Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities. Learn more about Genentech.

Fellows will spend 90% of their time on duties specific to the industry site and 10% of time on professional development activities with the Thomas J. Long School of Pharmacy. All fellows will be eligible for adjunct faculty status.

Fellowship Program Dates

The fellowship begins on July 1, 2021 and ends on June 30, 2023.

This position is currently not open for recruitment until Fall of 2020.